WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001031013) HUMAN GOLD-INDUCED GLYCOPROTEIN 30-LIKE PROTEIN AND NUCLEIC ACID ENCODING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/031013    International Application No.:    PCT/US2000/029559
Publication Date: 03.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed:    17.05.2001    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01)
Applicants: CURAGEN CORPORATION [US/US]; 11th Floor, 555 Long Wharf Drive, New Haven, CT 06511 (US) (For All Designated States Except US).
LEWIN, David, A. [US/US]; (US) (For US Only).
STEWART, Timothy, A. [US/US]; (US) (For US Only)
Inventors: LEWIN, David, A.; (US).
STEWART, Timothy, A.; (US)
Agent: RAUCH, Paul, E.; Brinks Hofer Gilson & Lione, P.O. Box 10087, Chicago, IL 60610 (US)
Priority Data:
60/161,978 28.10.1999 US
09/698,369 26.10.2000 US
Title (EN) HUMAN GOLD-INDUCED GLYCOPROTEIN 30-LIKE PROTEIN AND NUCLEIC ACID ENCODING THE SAME
(FR) PROTEINE HUMAINE DE TYPE GLYCOPROTEINE 30 INDUITE PAR LE FROID ET ACIDES NUCLEIQUES CODANT POUR CELLE-CI
Abstract: front page image
(EN)The invention provides a novel human cold-induced glycoprotein-30-like protein (hCig30L protein) and isolated nucleic acid molecules encoding the same. Also provided are antibodies that immunospecifically-bind to hCig30L polypeptide or polynucleotide, or derivatives, variants, mutants, or fragments thereof. The invention additionally provides methods in which the hCig30L polypeptide, polynucleotide, and antibody are used in the detection, prevention, and treatment of a broad range of pathological states, and methods of treating obesity-related disorders or modulating thermogenesis by modulating activity or expression of hCig30L protein.
(FR)L'invention concerne une nouvelle protéine humaine de type glycoprotéine 30 induite par le froid (protéine hCig30L), ainsi que des molécules d'acides nucléiques isolées codant pour celle-ci. L'invention concerne également des antibiotiques liant de manière immunospécifique le polypeptide ou le polynucléotide hCig30L, ou leurs dérivés, variants, mutants ou fragments. L'invention concerne en outre des techniques dans lesquelles on utilise le polypeptide, le polynucléotide et l'anticorps hCig30L dans la détection, la prévention et le traitement de nombreux états pathologiques, ainsi que des techniques permettant de traiter les troubles liés à l'obésité ou de moduler la thermogenèse par la modulation de l'activité ou de l'expression de la protéine hCig30L.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)